HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NIP 151

an IK(ACh) blocker

Also Known As:

NIP-151; NIP151

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - NIP 151: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - NIP 151: 1

Experts

1.	Asakura, Masanori: 1 article (01/2019)
2.	Asano, Yoshihiro: 1 article (01/2019)
3.	Asanuma, Hiroshi: 1 article (01/2019)
4.	Ebana, Yusuke: 1 article (01/2019)
5.	Fujita, Masashi: 1 article (01/2019)
6.	Furukawa, Tetsushi: 1 article (01/2019)
7.	Hashimoto, Norio: 1 article (01/2019)
8.	Hayashi, Kenshi: 1 article (01/2019)
9.	Horie, Minoru: 1 article (01/2019)
10.	Inanobe, Atsushi: 1 article (01/2019)

Related Diseases

1.	Bradycardia 01/01/2019 - "It is interesting to note that the selective IKACh channel blocker NIP-151 repressed the increased current and improved bradyarrhythmia phenotypes in the mutant zebrafish. " 01/01/2019 - "The IKACh channel is associated with the pathophysiology of bradyarrhythmia and atrial fibrillation, and the mutant IKACh channel ( KCNJ3 p.N83H) can be effectively inhibited by NIP-151, a selective IKACh channel blocker. "
2.	Atrial Fibrillation 01/01/2019 - "The IKACh channel is associated with the pathophysiology of bradyarrhythmia and atrial fibrillation, and the mutant IKACh channel ( KCNJ3 p.N83H) can be effectively inhibited by NIP-151, a selective IKACh channel blocker. "